CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction

ConclusionsThe CHA2DS2-VASc and ATRIA scores are associated with risks of adverse outcomes in HFpEF patients. However, the predictive abilities of CHA2DS2-VASc and ATRIA are modest, and their clinical utility in HFpEF remains to be determined.Clinical trial registrationhttps://clinicaltrials.gov. Identifier: NCT00094302
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research